DAVIS JAMES L

USNatural personDirector

Insider

DAVIS JAMES L

USNatural personDirector

Transactions

183

Issuers

Buys / Sells

32/1

Last tx

15 Mar 2017

Behaviour

3 purchases reported after at least 12 months of silence — most recent on 06 Jul 2016.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
ProUroCare Medical Inc.	75,000	reported	15 Jan 2014	tx 122+6,162,386−2,069,059
DE Acquisition 2, Inc.	0	reported	15 Mar 2017	tx 65+11,530,000−881,559

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
02 Mar 2017	OTHER	DE Acquisition 2, Inc.	24,024	0.00 USD	deriv
25 Jan 2017	GRANT_AWARD	DE Acquisition 2, Inc.	28,704	0.00 USD	deriv
15 Mar 2017	PURCHASE	DE Acquisition 2, Inc.	367,275	—	deriv
26 Jan 2017	GRANT_AWARD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
ProUroCare Medical Inc.	75,000	reported	15 Jan 2014	tx 122+6,162,386−2,069,059
DE Acquisition 2, Inc.	0	reported	15 Mar 2017	tx 65+11,530,000−881,559

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
02 Mar 2017	OTHER	DE Acquisition 2, Inc.	24,024	0.00 USD	deriv
25 Jan 2017	GRANT_AWARD	DE Acquisition 2, Inc.	28,704	0.00 USD	deriv
15 Mar 2017	PURCHASE	DE Acquisition 2, Inc.	367,275	—	deriv
26 Jan 2017	GRANT_AWARD